Ana Carolina Palma

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal

Ana Carolina Palma, Fernando Araújo, Vítor Duque et al. · Infection Genetics and Evolution · 2007 · 78 citations · Full text

Health Sciences, Molecular Epidemiology, Treatment And Prevention +10

Comparison of the COBAS TAQMAN™ HIV-1 HPS with VERSANT HIV-1 RNA 3.0 Assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes

Perpétua Gómes, Ana Carolina Palma, Joaquim Cabanas et al. · Journal of Virological Methods · 2006 · 16 citations

Medicine, Human Retrovirus, Immunology +6

Optimization of a Chemiluminescent Dot-Blot Immunoassay for Detection of Potato Viruses

Ana Carolina Palma, Rajitha Kota, Amy O. Charkowski · American Journal of Potato Research · 2013 · 12 citations

Chemiluminescent Dot-blot Immunoassay, Diagnostic Virology, Plant Virus +8

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G

Ana Carolina Palma, Ana Abecasis, Jurgen Vercauteren et al. · Infection Genetics and Evolution · 2009 · 11 citations

Subtypes B, Human Retrovirus, Immunology +9

HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G

Ana Carolina Palma, Kris Covens, J. Snoeck et al. · Journal of Antimicrobial Chemotherapy · 2012 · 10 citations · Full text